Fluad Vaccine for Influenza

"The Fluad Vaccine has been approved, so it is perceived to have a safety level of 3 on our team's rating scale."

"Unfortunately, this medical trial has ceased recruitment and is no longer seeking candidates. It was initially posted on September 23rd 2018 and the last edit ocurred on May 20th 2022. However, there are currently 63 studies actively enrolling those suffering from influenza-induced flu and 14 trials using Fluad Vaccine that welcome new participants."

"As per information on clinicaltrials.gov, this research project is no longer accepting volunteers as recruitment concluded on May 20th 2022. The trial was initially posted September 23rd 2018. Nevertheless, there are currently 77 other studies recruiting participants at the moment."

"Currently, 14 clinical trials are underway for the Fluad Vaccine. Of these studies, 1 is in its final phase of development; Phase 3. While most sites recruiting patients are based in Miami, Florida there exist 15 other locations conducting research on this vaccine."

"At the moment, 14 studies involving Fluad Vaccine are active in 10 cities across 3 countries. The first clinical trial of this vaccine was conducted by Pharmacyclics LLC and concluded its Phase 2 approval stage with 42 enrolled patients in 2016. Since then, 159 related trials have been finalised."